ab88503 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab88503 は 2 報の論文で使用されています。

  • Angelika Ihle M  et al. HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat. J Pathol Clin Res 2:59-71 (2016). WB . PubMed: 27499916
  • Yeo W  et al. Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group. J Clin Oncol 30:3361-7 (2012). IHC ; Human . PubMed: 22915658

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録